Disney's "Avengers: Endgame" is now the highest-grossing film of all time having earned $2.79 billion at the global box office.Entertainmentread more
Peter Neupert worked for Microsoft and Amazon-backed Drugstore.com, where he got to know Jeff Bezos. He now advises start-ups.Technologyread more
Regional stability, oil prices and potential for war will all depend on what Iran does with its nuclear program in the event of the deal's termination.World Politicsread more
Instagram began tests that hide "like" counts on posts. That means influencers who market products on Instagram will have to rely on different metrics to show success.Technologyread more
Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
Moving lots of data to a public cloud over the internet can take months or years. CNBC got an inside look at how AWS transfers data to the cloud for its clients.Technologyread more
Amazon's new policy for account suspensions doesn't go far enough to protect sellers from potentially unfair and wrongful suspensions, merchants say.Technologyread more
There is no end in sight to the Boeing 737 Max grounding after two fatal crashes, prompting airlines to rethink their growth plans.Airlinesread more
After a year of flooding, Midwest farmers face a stifling heat wave that's spreading across the U.S.Weather & Natural Disastersread more
On Saturday, Disney's Marvel Studios announced its upcoming slate of superhero films during a panel at San Diego Comic-Con.Entertainmentread more
"It troubles me that the most important political office in the world is becoming the face of racism and exclusion," Kaeser said in a Twitter post.Politicsread more
Investors looking to find names that can soar 50 percent or more over the next year have to be prepared to take some risks, two investment experts said Wednesday.
If they are willing to do so, there are a couple of names that may fit the bill.
For David Sowerby, portfolio manager at Loomis, Sayles & Co., the recipe for finding that kind of company comes down to a couple of things.
"First, is there mistrust or doubtfulness in investor sentiment? Second, is the company's fundamentals improving off the bottom, is it still trading well below its high over the last couple of years?" he said in an interview with CNBC's "Closing Bell. "
Sowerby believes Genesee & Wyoming, a mid-cap rail company, has the potential to make such a move.
There are seven "buys" and six "holds" by Wall Street analysts on the stock, and it is still trading well below its 2015 high of $105 a share, he said. Plus, fundamentals appear to be improving and it is growing its free cash flow.
Steve Dudash, president of IHT Wealth Management, thinks Gilead Sciences may be a good bet on a 50 percent jump.
The biotech sector has been beaten up "really bad," and people are wondering what Gilead is going to do with its freed-up cash, he said.
"If you are going to do this and you are willing to take the risk to do it, you're betting on the fact that they are going to do something with that cash — they've got $25 billion, give or take, in cash out there — and a track record of buying really good companies that end up being the next HIV drug or the next Hep C drug," Dudash told "Closing Bell."
He also thinks Twitter has a chance at 50 percent gains because of its merger and acquisitions prospects.
"We all know they've got problems," he said. "Some company out there could take them over. They've got a huge base."